UB
TXG icon

UMB Bank’s 10x Genomics TXG Stock Holding History

UMB Bank’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-482
Closed -$9.38K – 2194
2024
Q2 		$9.38K Buy
482
+113
+31% +$2.96K ﹤0.01% 1277
2024
Q1 		$13.8K Sell
369
-413
-53% -$18.1K ﹤0.01% 1199
2023
Q4 		$43.8K Buy
782
+266
+52% +$11.6K ﹤0.01% 862
2023
Q3 		$21.3K Sell
516
-144
-22% -$7.49K ﹤0.01% 1062
2023
Q2 		$36.9K Sell
660
-9
-1% -$487 ﹤0.01% 918
2023
Q1 		$37.3K Buy
669
+164
+32% +$7.66K ﹤0.01% 918
2022
Q4 		$18K Buy
505
+79
+19% +$2.58K ﹤0.01% 1142
2022
Q3 		$12K Buy
426
+201
+89% +$7.66K ﹤0.01% 1263
2022
Q2 		$10K Buy
225
+104
+86% +$5.4K ﹤0.01% 1405
2022
Q1 		$9K Buy
+121
New +$10.6K ﹤0.01% 1526

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

UMB Bank's TXG Position: Q3 2024 in Review

UMB Bank sold out of 10x Genomics (TXG) in Q3 2024, closing a stake of 482 shares — an estimated $9.38K sold.

UMB Bank first reported a position in TXG in Q1 2022 and held it in 10 quarters. The position peaked at $43.8K in Q4 2023. 266 funds tracked by Wall St. Rank hold TXG as of Q3 2024.

  • UMB Bank reported no remaining 10x Genomics position as of Q3 2024 after selling out during the quarter.
  • UMB Bank sold 482 10x Genomics shares in Q3 2024, an estimated $9.38K.
  • UMB Bank first reported a position in 10x Genomics in Q1 2022 and held it in 10 quarters.
  • UMB Bank's 10x Genomics position peaked at $43.8K in Q4 2023.
  • 266 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2024.

Based on UMB Bank's 13F filing for Q3 2024, filed 9 Oct 2024.